Habib J. Dable
Chief Executive Officer, Acceleron Pharma.
Companies
- Tyra Biosciences, Inc.Board member Apr 20, 2026 to now1
- SpyGlass Pharma, Inc.Board member Feb 5, 2026 to now2
- Relay TherapeuticsBoard member Nov 6, 2025 to now3
- Day One Biopharmaceuticals, Inc.Board member Jan 19, 2024 to now4
- PepGen Inc.Board member Sep 22, 2022 to now5
- Blueprint Medicines CorpBoard member Jun 27, 2022 to now6
- Jade Biosciences, Inc.Board member Jul 11, 2023 to Jun 7, 20247
- ALBIREO PHARMA, INC.Board member Aug 10, 2022 to Mar 2, 20238
- Acceleron PharmaBoard member Dec 5, 2016 to Nov 22, 20219
- Acceleron PharmaChief executive officer Dec 5, 2016 to Nov 22, 20219
- Acceleron PharmaPresident Dec 5, 2016 to Nov 22, 20219
- Tempest Therapeutics, Inc.Board member Dec 11, 2018 to Jun 23, 202010
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Acceleron Pharma XLRN0 shares11Nov 19, 2021
- Blueprint Medicines Corp0 shares12Jul 17, 2025
- Tyra Biosciences, Inc. TYRA0 shares13Apr 20, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 17, 2025U 8,742 shares of Blueprint Medicines Corp12
- Jul 17, 2025Returned to company 3,902 shares of Blueprint Medicines Corp12
- Jun 18, 2025Granted 3,902 shares at $128.12 of Blueprint Medicines Corp14
- Jun 12, 2024Granted 2,242 shares of Blueprint Medicines Corp15
- Jun 21, 2023Granted 2,600 shares of Blueprint Medicines Corp16
- Jun 23, 2022Granted 3,900 shares of Blueprint Medicines Corp17
- Nov 19, 2021U 98,450 shares of Acceleron Pharma11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARTyra Biosciences, Inc., Board member
- 2SEC EDGARSpyGlass Pharma, Inc., Board member
- 3SEC EDGARRelay Therapeutics, Board member
- 4
- 5SEC EDGARPepGen Inc., Board member
- 6
- 7SEC EDGARJade Biosciences, Inc., Board member
- 8SEC EDGARALBIREO PHARMA, INC., Board member
- 9SEC EDGARAcceleron Pharma, Board member
- 10
- 11
- 12
- 13
- 14SEC EDGARForm 4 filed Jun 24, 2025
- 15SEC EDGARForm 4 filed Jun 14, 2024
- 16SEC EDGARForm 4 filed Jun 23, 2023
- 17SEC EDGARForm 4 filed Jun 27, 2022